Lu-177-PNT6555
177Lu-PNT6555 (part of the PNT2004 development program) is a molecule [...]
Lu-177-Ludotadipep
177Lu-Ludotadipep (177Lu-FC705) is a 177Lu-labeled analogue of 177Lu-Vipivotide targeting PSMA. [...]
Lu-177-rhPSMA-10.1
rhPSMA (radiohybrid PSMA) is a prostate specific membrane antigen labeled [...]
Lu-177-EDTMP
177Lu-EDTMP is the 177Lu equivalent of 153Sm-Lexidronam developed for the same [...]
Lu-177-Oxodotreotide (Lutathera®)
177Lu-Oxodotreotide (177Lu-Lutathera®, 177Lu-DOTATATE) is a radiolabeled somatostatin analogue developed [...]
Lu-177-Vipivotide tetraxetan (Pluvicto™)
177Lu-Vipivotide tetratexan (177Lu-PSMA-617) is a 177Lu labeled peptide developed [...]
Lu-177-MVT-1075
177Lu-MVT-1075 is the therapeutic counterpart of 89Zr-DFO-HuMab-5B1 developed for the [...]
Lu-177-Satoreotide tetraxetan
177Lu-Satoreotide tetratexan (177Lu-OPS201, 177Lu-DOTA-JR11) is the lutetium-177 analogue of [...]
Lu-177-Pentixather
177Lu-Pentixather is the therapeutic analogue of 68Ga-Pentixafor, to be used [...]
Lu-177-ST2210 (IART – Lu-177 DOTA-Biotin)
IART® stands for Intraoperative Avidination for Radionuclide Treatment. It is [...]